The rumors earlier this week about an acquisition of Sepracor Inc. by Dainippon Sumitomo Pharma Co. (DSP) Ltd., which drove shares of the Marlborough, Mass.-based firm up 26 percent Wednesday, proved true early Thursday, with the Japanese drugmaker bidding $23 per share, or about $2.6 billion, for Sepracor. (BioWorld Today) Read More
